PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Trial Details

NCT ID
NCT06945484
Phase
NA
Sponsor
University of Utah
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Precision Exercise Regimen for Cancer Care (PERCC)
Locations (sample)
  • Galveston, Texas, United States|29.30135,-94.7977
  • Salt Lake City, Utah, United States|40.76078,-111.89105

Key Eligibility Criteria

  • Ages 18 and older at time of diagnosis
  • Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
  • Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
  • Patient able to follow direction and complete questionnaires in English or Spanish

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →